Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04672434
Title Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Symphogen A/S
Indications

lung adenocarcinoma

pancreatic ductal adenocarcinoma

colorectal carcinoma

gastroesophageal cancer

stomach carcinoma

peritoneal mesothelioma

esophageal carcinoma

cholangiocarcinoma

malignant pleural mesothelioma

head and neck squamous cell carcinoma

Therapies

Sym021 + Sym024

Sym024

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.